The Affordable Care Act has had many impacts on the U.S. Healthcare industry, including accelerating the development of many new forms of healthcare provider networks. The rise of Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs) has forced pharmaceutical organizations to adjust their commercial models and activities to better work with these critical new networks.
Best Practices, LLC designed this benchmarking study to better understand the current and expected impact of ACOs/IDNs on pharma companies’ operations. The study will assist sales and managed markets leaders in developing an effective strategy for serving provider networks such as ACOs and IDNs.
Read more at: http://www.best-in-class.com/bestp/domrep.nsf/products/optimizing-managed-markets-function-roles-structures-resources-activities?OpenDocument